MYDA Advisors’s MedTech Acquisition Corporation Unit MTACU Stock Holding History

MYDA Advisors’s Portfolio MTACU Stock Details MTACU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-200,000	Closed	-$2.01M	–	365
2021 Q1	$2.01M	Sell	200,000 -200,000	-50%	-$2.13M	0.56%	59
2020 Q4	$4.2M	Buy	+400,000	New	+$4.17M	1.25%	19

Other funds holding MTACU

Wellington Management Group

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Hartree Partners New York $467M AUM 66.71% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Islet Management New York $49.1M AUM 17.59% 1-Year Est. Return

MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return

Bracebridge Capital LLC Boston, Massachusetts $3.73B AUM 33.02% 1-Year Est. Return

Zeke Capital Advisors Berwyn, Pennsylvania $1.53B AUM 17.37% 1-Year Est. Return

Millennium Management

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return

Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return

MYDA Advisors's MTACU Position: Q2 2021 in Review

MYDA Advisors sold out of MedTech Acquisition Corporation Unit (MTACU) in Q2 2021, closing a stake of 200,000 shares — an estimated $2.01M sold.

MYDA Advisors first reported a position in MTACU in Q4 2020 and held it in 2 quarters. The position peaked at $4.2M in Q4 2020. 30 funds tracked by Wall St. Rank hold MTACU as of Q2 2021.

MYDA Advisors reported no remaining MedTech Acquisition Corporation Unit position as of Q2 2021 after selling out during the quarter.
MYDA Advisors sold 200,000 MedTech Acquisition Corporation Unit shares in Q2 2021, an estimated $2.01M.
MYDA Advisors first reported a position in MedTech Acquisition Corporation Unit in Q4 2020 and held it in 2 quarters.
MYDA Advisors's MedTech Acquisition Corporation Unit position peaked at $4.2M in Q4 2020.
30 funds tracked by Wall St. Rank held MedTech Acquisition Corporation Unit as of Q2 2021.

Based on MYDA Advisors's 13F filing for Q2 2021, filed 13 Aug 2021.